Chenyang Shi
Director/Miembro de la Junta en GENSCRIPT BIOTECH CORPORATION .
Perfil
Chenyang Shi was the founder of NuProbe USA, Inc., a company founded in 2016, where he held the title of Chief Executive Officer.
He is currently working as an Independent Non-Executive Director at Genscript Biotech Corp.
since 2024.
Dr. Shi has a graduate and doctorate degree from Rochester Christian University.
He also holds an undergraduate degree from the University of Science & Technology of China, which he received in 1986.
Cargos activos de Chenyang Shi
| Empresas | Cargo | Inicio |
|---|---|---|
| GENSCRIPT BIOTECH CORPORATION | Director/Miembro de la Junta | 12/04/2024 |
Antiguos cargos conocidos de Chenyang Shi.
| Empresas | Cargo | Fin |
|---|---|---|
NuProbe USA, Inc.
 NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA. | Fundador | - |
Formación de Chenyang Shi.
| Rochester Christian University | Doctorate Degree |
| University of Science & Technology of China | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GENSCRIPT BIOTECH CORPORATION | Health Technology |
| Empresas privadas | 1 |
|---|---|
NuProbe USA, Inc.
NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Chenyang Shi
